<DOC>
	<DOCNO>NCT03027089</DOCNO>
	<brief_summary>Aspergillus-specific IgG assay diagnosis chronic pulmonary aspergillosis ( CPA )</brief_summary>
	<brief_title>Aspergillus-specific IgG Assays Diagnosis Chronic Pulmonary Aspergillosis ( CPA ) -Multicenter Study</brief_title>
	<detailed_description>chronic pulmonary aspergillosis ( CPA ) one refractory pulmonary infectious disease , incidence increase rapidly recent year . Serum detection Aspergillus-specific IgG consider reliable method diagnose CPA , however , formal report appropriate cut-off value Aspergillus-specific IgG assay Chinese patient . This study aim establish datum . Besides aspergillus-specific IgG , two specific antibody IgM IgA . IgM associate acute phase infection IgA associate mucosal immunity . Their diagnostic value CPA still clear . Meanwhile , whether detection antibody level bronchoalveolar lavage fluid ( BALF ) could useful diagnosis CPA investigate . In study , serum BALF level IgG , IgM IgA would detect simultaneously commercial available kit . The investigator establish cut-off value three antibody proven CPA patient negative control . Then , cut-off value assess participant suspect CPA , sensitivity , specificity , positive negative predict value antibodies assay compare standard diagnostic method . After perform diagnostic test , CPA could diagnose accurately rapidly , antifungal therapy could evaluate correctly timely .</detailed_description>
	<mesh_term>Aspergillosis</mesh_term>
	<mesh_term>Pulmonary Aspergillosis</mesh_term>
	<criteria>18 year 85 year Lesions present cavity , nodule，mass `` destroyed lung '' cause fibrosis CT image seriously immunocompromised patient 1 . Recent history neutropenia ( ＜0.5 × 109neutrophils/L [ ＜500 neutrophils/mm3 ] for＞10 day ) temporally relate onset fungal disease 2 . Receipt allogeneic stem cell transplant 3 . Prolonged use corticosteroid ( exclude among patient allergic bronchopulmonary aspergillosis ) mean minimum dose 0.3 mg/kg/day prednisone equivalent ＞3 week 4 . Treatment recognize T cell immunosuppressant , cyclosporine , TNFa blocker , specific monoclonal antibody ( alemtuzumab ) , nucleoside analogues past 90 day 5 . Inherited severe immunodeficiency ( chronic granulomatous disease severe combine immunodeficiency ) antifungal drug use within 3 month screen dropout Pregnancy lactation inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Aspergillus-specific IgG</keyword>
</DOC>